Microbial influence: The characteristic dysbiosis in IBD could alter microbial metabolites (e.g., short-chain fatty acids) or pathogen-associated molecular patterns (e.g., LPS), which might impair NAT10 expression via Toll-like receptor (TLR) signaling. This evidence concerns the gene NAT10 and inflammatory bowel disease.